Key Points
- Insider buy: OneMedNet insider Jeffrey Yu purchased 1,666,666 shares on June 20 at $0.42 each (~$699,999.72), increasing his direct ownership to 6,737,410 shares — a 32.87% rise valued at about $2.83M.
- Stock reaction and metrics: Shares jumped ~20.8% to open at $1.72 on the news; the company has a market cap of $87.47M, a 1‑year range of $0.30–$4.22, a negative P/E, and 50/200‑day moving averages of $1.80 and $1.00 respectively.
- Market view: Despite the insider accumulation, analysts hold a consensus "Sell" rating and institutional ownership remains low (~0.95%), though a few funds have recently taken or increased small positions.
OneMedNet Corporation (NASDAQ:ONMD - Get Free Report) insider Jeffrey Yu acquired 1,666,666 shares of the stock in a transaction on Friday, June 20th. The stock was bought at an average price of $0.42 per share, with a total value of $699,999.72. Following the transaction, the insider directly owned 6,737,410 shares in the company, valued at approximately $2,829,712.20. This represents a 32.87% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Jeffrey Yu also recently made the following trade(s):
- On Thursday, September 25th, Jeffrey Yu bought 1,250 shares of OneMedNet stock. The shares were bought at an average price of $1.03 per share, for a total transaction of $1,287.50.
- On Wednesday, September 24th, Jeffrey Yu purchased 17,200 shares of OneMedNet stock. The shares were bought at an average cost of $1.02 per share, for a total transaction of $17,544.00.
- On Tuesday, September 23rd, Jeffrey Yu purchased 5,700 shares of OneMedNet stock. The stock was bought at an average cost of $0.93 per share, with a total value of $5,301.00.
- On Monday, September 22nd, Jeffrey Yu acquired 400 shares of OneMedNet stock. The stock was bought at an average price of $0.95 per share, with a total value of $380.00.
- On Friday, September 19th, Jeffrey Yu acquired 1,250 shares of OneMedNet stock. The stock was purchased at an average price of $0.89 per share, for a total transaction of $1,112.50.
- On Thursday, September 18th, Jeffrey Yu bought 700 shares of OneMedNet stock. The stock was purchased at an average cost of $0.91 per share, with a total value of $637.00.
- On Friday, September 5th, Jeffrey Yu bought 2,100 shares of OneMedNet stock. The shares were purchased at an average price of $0.86 per share, with a total value of $1,806.00.
- On Thursday, September 4th, Jeffrey Yu purchased 11,810 shares of OneMedNet stock. The shares were purchased at an average cost of $0.87 per share, for a total transaction of $10,274.70.
- On Wednesday, September 3rd, Jeffrey Yu purchased 11,670 shares of OneMedNet stock. The stock was purchased at an average price of $0.81 per share, for a total transaction of $9,452.70.
- On Tuesday, September 2nd, Jeffrey Yu acquired 24,319 shares of OneMedNet stock. The stock was purchased at an average price of $0.85 per share, with a total value of $20,671.15.
OneMedNet Trading Up 20.8%
Shares of NASDAQ:ONMD opened at $1.72 on Friday. OneMedNet Corporation has a 1-year low of $0.30 and a 1-year high of $4.22. The stock has a market capitalization of $87.47 million, a P/E ratio of -34.30 and a beta of 1.09. The business has a 50-day moving average price of $1.80 and a two-hundred day moving average price of $1.00.
OneMedNet (NASDAQ:ONMD - Get Free Report) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.18 million for the quarter.
Hedge Funds Weigh In On OneMedNet
Several institutional investors and hedge funds have recently made changes to their positions in the company. Ashton Thomas Private Wealth LLC bought a new stake in shares of OneMedNet in the 3rd quarter valued at $25,000. Exencial Wealth Advisors LLC grew its stake in OneMedNet by 3.1% in the second quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company's stock valued at $851,000 after acquiring an additional 45,448 shares during the period. Finally, Correct Capital Wealth Management acquired a new position in OneMedNet in the third quarter valued at about $4,910,000. Institutional investors and hedge funds own 0.95% of the company's stock.
Analyst Ratings Changes
Several analysts have commented on ONMD shares. Wall Street Zen upgraded shares of OneMedNet to a "hold" rating in a research report on Friday, September 26th. Weiss Ratings reiterated a "sell (d-)" rating on shares of OneMedNet in a report on Tuesday, October 14th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of "Sell".
Check Out Our Latest Research Report on ONMD
About OneMedNet
(
Get Free Report)
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
